Citigroup’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,000
| Closed | -$3K | – | 5605 |
|
|
2021
Q2 | $3K | Sell |
1,000
-285
| -22% | -$855 | ﹤0.01% | 5263 |
|
|
2021
Q1 | $4K | Buy |
1,285
+1,000
| +351% | +$3.11K | ﹤0.01% | 5298 |
|
|
2020
Q4 | $1K | Sell |
285
-2
| -0.7% | -$7 | ﹤0.01% | 5163 |
|
|
2020
Q3 | $1K | Sell |
287
-75
| -21% | -$261 | ﹤0.01% | 4999 |
|
|
2020
Q2 | $1K | Sell |
362
-1,472
| -80% | -$4.07K | ﹤0.01% | 5002 |
|
|
2020
Q1 | $4K | Buy |
1,834
+471
| +35% | +$1.03K | ﹤0.01% | 4861 |
|
|
2019
Q4 | $5K | Buy |
1,363
+473
| +53% | +$1.74K | ﹤0.01% | 4884 |
|
|
2019
Q3 | $2K | Sell |
890
-515
| -37% | -$1.16K | ﹤0.01% | 4979 |
|
|
2019
Q2 | $5K | Sell |
1,405
-7,708
| -85% | -$27.4K | ﹤0.01% | 4896 |
|
|
2019
Q1 | $221K | Buy |
+9,113
| New | +$221K | ﹤0.01% | 3059 |
|
|
2018
Q3 | – | Sell |
-3
| Closed | – | – | 5166 |
|
|
2018
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 5121 |
|
|
2018
Q1 | $0 | Hold |
3
| – | – | ﹤0.01% | 5052 |
|
|
2017
Q4 | $0 | Hold |
3
| – | – | ﹤0.01% | 5038 |
|
|
2017
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 4919 |
|
|
2016
Q2 | – | Sell |
-31
| Closed | -$1K | – | 5359 |
|
|
2016
Q1 | $1K | Buy |
+31
| New | +$1K | ﹤0.01% | 5251 |
|
|
2015
Q4 | – | Sell |
-295
| Closed | -$10K | – | 5723 |
|
|
2015
Q3 | $10K | Buy |
295
+280
| +1,867% | +$9.49K | ﹤0.01% | 4396 |
|
|
2015
Q2 | $1K | Buy |
+15
| New | +$1K | ﹤0.01% | 5394 |
|
|
2015
Q1 | – | Sell |
-13
| Closed | -$1K | – | 5713 |
|
|
2014
Q4 | $1K | Buy |
13
+2
| +18% | +$154 | ﹤0.01% | 5364 |
|
|
2014
Q3 | $1K | Buy |
+11
| New | +$1K | ﹤0.01% | 5298 |
|
|
2014
Q1 | – | Sell |
-1
| Closed | – | – | 5611 |
|
|
2013
Q4 | $0 | Sell |
1
-26
| -96% | – | ﹤0.01% | 5506 |
|
|
2013
Q3 | $5K | Buy |
+27
| New | +$5K | ﹤0.01% | 4778 |
|